Covea Finance Eli Lilly & CO Transaction History
Covea Finance
- $2.68 Billion
- Q2 2025
A detailed history of Covea Finance transactions in Eli Lilly & CO stock. As of the latest transaction made, Covea Finance holds 44,470 shares of LLY stock, worth $33.2 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
44,470
Previous 31,100
42.99%
Holding current value
$33.2 Million
Previous $25.7 Million
34.96%
% of portfolio
1.29%
Previous 1.17%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
4,404Shares Held
807MCall Options Held
9.91MPut Options Held
10.9M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$75.6 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$71.7 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$59.1 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$49.2 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$25.7 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $709B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...